|
Market Closed -
Nasdaq
16:00:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 525.73 USD | -0.74% |
|
+8.44% | +15.96% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 133B | AA | |||||||
| 1,088B | A | |||||||
| 629B | - | BBB | - | - | ||||
| 440B | - | AA | - | - | ||||
| 359B | AA | |||||||
| 291B | AAA | |||||||
| 245B | A | |||||||
| 225B | A | |||||||
| 204B | A | |||||||
| 168B | AA | |||||||
| 150B | A | |||||||
| 130B | A | |||||||
| 104B | AA | |||||||
| 101B | AA | |||||||
| 74.22B | AA | |||||||
| 55.77B | AA | |||||||
| 54.43B | AA | |||||||
| 53.12B | AA | |||||||
| 42.82B | AA | |||||||
| 42.81B | - | |||||||
| Average | 229.56B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
